ATE533758T1 - Verfahren zur herstellung von enantiomerenreinem esomeprazol - Google Patents

Verfahren zur herstellung von enantiomerenreinem esomeprazol

Info

Publication number
ATE533758T1
ATE533758T1 AT07827582T AT07827582T ATE533758T1 AT E533758 T1 ATE533758 T1 AT E533758T1 AT 07827582 T AT07827582 T AT 07827582T AT 07827582 T AT07827582 T AT 07827582T AT E533758 T1 ATE533758 T1 AT E533758T1
Authority
AT
Austria
Prior art keywords
methoxy
esomeprazole
pure esomeprazole
camphorsulfonyl
sulfinyl
Prior art date
Application number
AT07827582T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Application granted granted Critical
Publication of ATE533758T1 publication Critical patent/ATE533758T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT07827582T 2007-09-25 2007-09-25 Verfahren zur herstellung von enantiomerenreinem esomeprazol ATE533758T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2007/000433 WO2009040825A1 (en) 2007-09-25 2007-09-25 A process for preparation of enantiomerically pure esomeprazole

Publications (1)

Publication Number Publication Date
ATE533758T1 true ATE533758T1 (de) 2011-12-15

Family

ID=40510780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07827582T ATE533758T1 (de) 2007-09-25 2007-09-25 Verfahren zur herstellung von enantiomerenreinem esomeprazol

Country Status (7)

Country Link
US (1) US7947840B2 (de)
EP (1) EP2106397B1 (de)
AT (1) ATE533758T1 (de)
DK (1) DK2106397T3 (de)
ES (1) ES2375515T3 (de)
PT (1) PT2106397E (de)
WO (1) WO2009040825A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2789298A1 (en) 2010-02-12 2011-08-18 Esteve Quimica, S.A. Preparation process of the sodium salt of esomeprazole
CN102285970B (zh) * 2011-09-21 2014-07-23 石药集团欧意药业有限公司 一种埃索美拉唑化合物、制备方法及其药物组合物
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
GB2376231A (en) 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
WO2004002982A2 (en) 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
EP1633736A1 (de) 2003-05-05 2006-03-15 Ranbaxy Laboratories Limited Barium salz eines benzimidazol-derivats
EP1740571B1 (de) 2004-04-28 2009-07-29 Hetero Drugs Limited Verfahren zur herstellung von pyridinylmethyl-1h-benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
SI1802584T1 (sl) * 2004-10-11 2010-01-29 Ranbaxy Lab Ltd Postopki za pripravo substituiranih sulfoksidov
KR20080007508A (ko) 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법

Also Published As

Publication number Publication date
EP2106397B1 (de) 2011-11-16
PT2106397E (pt) 2012-01-23
WO2009040825A1 (en) 2009-04-02
US20100174087A1 (en) 2010-07-08
US7947840B2 (en) 2011-05-24
ES2375515T3 (es) 2012-03-01
EP2106397A4 (de) 2010-04-07
EP2106397A1 (de) 2009-10-07
DK2106397T3 (da) 2012-01-30

Similar Documents

Publication Publication Date Title
ATE475655T1 (de) Verfahren zur herstellung von (s)-4- fluormethyldihydrofuran-2-on
EA200900817A1 (ru) Способ получения фторметилзамещённых гетероциклических соединений
AR063710A1 (es) Proceso para la preparacion de acido 6-(3-cloro-2-fluorbencil)-1-[(s)-1-hidroximetil-2-metilpropil]-7-metoxi-4-oxo-1, 4-dihidroquinolon-3-carboxilico como inhibidores de integrasa del hiv e intermediarios de sintesis del mismo y composiciones que lo comprenden.
GEP20074135B (en) Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)- benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
NZ592827A (en) Methods of preparing quinoline derivatives
TW201129555A (en) Process for the manufacture of dabigatrane etexilate
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE473221T1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus
ATE539054T1 (de) Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte
ME00814B (me) NOVI POSTUPAK SINTEZE 7,8-DIMETOKSI-1 ,3-DIHIDR0-2H-3-BENZAZEPIN-2-ON-a l PRIMENA U SINTEZI IVABRADINA l NJEGOVIH ADICIONIH SOLI SA FARMACEUTSKI PRIHVATLJIVOM KISELINOM
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
EA201990688A1 (ru) Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение
ATE518835T1 (de) Kristallform einer chinolinverbindung und verfahren zu deren herstellung
ATE533758T1 (de) Verfahren zur herstellung von enantiomerenreinem esomeprazol
ATE534643T1 (de) Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
ATE466010T1 (de) Verfahren zur herstellung von candesartan
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
CY1112979T1 (el) Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου
DE602006015241D1 (de) Verbessertes verfahren zur herstellung von rivastigmin
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ATE486867T1 (de) Verfahren zur herstellung von hochreinem meloxicam und meloxicam-kaliumsalz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2106397

Country of ref document: EP